Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

When last asked about writing a new article on $AMBS prior to the A.A.I.C. Jason stated that he was waiting until after the conference to write a new article. I assume he expected the LymPro data to be released at the conference.

Since the data was delayed until the C4CT Summit I expect Jason to publish a new article as soon as the LymPro data is released; possibly as early as Friday. I also expect a follow-up article after LymPro revenue projections are made and a partner is named.

The share price could be in the .40-.50 range by then.

Stay tuned for news.

"The trend is your friend but it's the science that will make you rich."

Twitter: @AmarantusBio .... 10,000+ followers.

"$AMBS - The next Amgen in its infancy"